Clinical Trials Browser

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Adenocarcinoma, Stomach Neoplasms

Esophageal Neoplasms

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Oropharyngeal Neoplasms

Esophageal Neoplasms, Thrombocytopenia

Lung Neoplasms

Resectable Esophageal Cancer

Carcinoma, Carcinoma, Squamous Cell

Rectal Neoplasms

Esophageal Neoplasms

Mouth Neoplasms

Mouth Neoplasms

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Rectal Neoplasms, Irritable Bowel Syndrome

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

Rectal Neoplasms, Colorectal Neoplasms

Brain Neoplasms, Glioblastoma, Melanoma

Adenocarcinoma Of Esophagus, Carcinoma, Squamous Cell

Pancreatic Neoplasms

Glioblastoma

Rectal Neoplasms

Nasopharyngeal Carcinoma

Carcinoma, Neoplasms, Neoplasms by Site, Rectal Neoplasms

Rectal Neoplasms

Uterine Cervical Neoplasms

Head and Neck Neoplasms

Head and Neck Neoplasms

Stomach Neoplasms

Breast Neoplasms, Pain

Head and Neck Neoplasms, Pharyngeal Neoplasms, Tonsillar Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Esophageal Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Clinical Trials

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

PREACT

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

OPTIMA-II

IMMUNEBOOST

The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer

Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus

CHINOREC

Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients

GAIN-1

Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

Long Term Bowel Function Following Rectal Cancer Surgery

Adjuvant CCRT vs CT in Minimal N2 NSCLC

Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

RectumSIB

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

NeoRes

LAPACT

Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme

TRUST

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

SPRINT

LARC-RRP

Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients

Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery

Induction Chemotherapy for Advanced Head and Neck Cancer

TRACE

Chemoradiation for Bone Metastasis

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

FOLFOX

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE)